Author(s):
Santosh Kumari Duppala, Smita C. Pawar, Ashish Vyas, Sugunakar Vure
Email(s):
dsantoshkumari87@gmail.com , smita.prof@gmail.com , ashish.vyas@lpu.co.in , sugunakarvure@gmail.com
DOI:
10.52711/0974-360X.2024.00361
Address:
Santosh Kumari Duppala1, Smita C. Pawar2, Ashish Vyas3, Sugunakar Vure4
1Department of Microbiology, School of Bioengineering and Biosciences, Jalandhar, Lovely Professional University, Punjab, India.
2Department of Genetics, Osmania University, Hyderabad, Telangana, India.
3Department of Microbiology, School of Bioengineering and Biosciences, Jalandhar, Lovely Professional University, Punjab, India.
4MNR Foundation for Research and Innovation, MNR Medical College and Hospital, MNR University, Fasalwadi Village, Sangareddy (District), Telangana, India-502294.
*Corresponding Author
Published In:
Volume - 17,
Issue - 5,
Year - 2024
ABSTRACT:
Cervical cancer is one of the most frequent cancers among women and the fourth leading cancer for mortality worldwide, and it is caused by persistent infections of Human papillomavirus (HPV). Most of the death cases are reported in developing countries like Africa and Southeast Asia. As the incidence and mortality rates increase globally, women with advanced and recurrent cancers are showing less response towards chemoradiotherapy. Hence, molecular therapies and targets show promising results. In our study, we have performed whole exome sequencing of 10 samples in a cohort and after analyzing received top mutated genes/ variants and one of the top variants in this study we focused on KMT2C rs ID 138908625 exon 8 regions Chr 7:152265083 variation C>A, T, protein structure prediction, c score, and TM value evaluated for wild type, Query 1 and Query for top 5 models of KMT2C by I TASSER. The predicted values of the models of KMT2C Query 2 show structural similarity and functional analog when compared to Query 1 with wild-type KMT2C. Further, protein-protein docking studies were performed using Cluspro 2.0 with the compounds of Arteminisin, Shikonin, Sitoinoside IX, Bucidarasin A, and Betulin with KMT2C. The Betulin shows better binding energy (-12.5 Kcal/mol) and followed by Bucidarasin (-12.3Kcal/mol) with KMT2C. The present study is the combination of insilico work with the whole exome sequencing variants, that can be used in the prognosis and diagnosis of cervical cancer. The docking studies predict the molecular binding affinities of the ligand and the protein fold conformations.
Cite this article:
Santosh Kumari Duppala, Smita C. Pawar, Ashish Vyas, Sugunakar Vure. Protein-Protein Docking and Structural Prediction of KMT2C Variant from Cervical Cancer Whole Exome Sequencing Data. Research Journal of Pharmacy and Technology. 2024; 17(5):2301-8. doi: 10.52711/0974-360X.2024.00361
Cite(Electronic):
Santosh Kumari Duppala, Smita C. Pawar, Ashish Vyas, Sugunakar Vure. Protein-Protein Docking and Structural Prediction of KMT2C Variant from Cervical Cancer Whole Exome Sequencing Data. Research Journal of Pharmacy and Technology. 2024; 17(5):2301-8. doi: 10.52711/0974-360X.2024.00361 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2024-17-5-57
REFERENCES:
1. Zhang S, Xu H, Zhang L, Qiao Y. Cervical cancer: Epidemiology, risk factors and screening. Chinese Journal of Cancer Research. 2020 Dec 12; 32(6): 720.
2. Prakasam A, Choudhary VS. To Assess the Effectiveness of Planned Teaching Programme on Knowledge and Attitude regarding Prophylactic Vaccination for preventing Cervical Cancer among nursing students in the College of Nursing, Bathinda, Punjab. International Journal of Advances in Nursing Management. 2019; 7(2): 143-7.
3. Handa S, Ahlawat P, Negi R. A Descriptive Study to assess the Knowledge regarding Cervical Cancer among selected Rural Areas of Gurugram, Haryana. Asian Journal of Nursing Education and Research. 2019; 9(4): 562-5.
4. Shadap A, Devi R, Bygrace M, Sun M, Siwakoti B, Bhutia PD. Knowledge on prevention of cervical cancer among women residing in selected urban and rural community in Sikkim. Asian Journal of Nursing Education and Research. 2017; 7(2): 219-21.
5. George JT, Batra K. Major determinants and various preventive strategies of cervical cancer. Asian Journal of Nursing Education and Research. 2015;5(3):420-4.
6. Al-Zwaini YK, Al-Mugdadi SF, Abbas WA. Detection of Novel apyrimidinic Endonuclease 1 (APE1) in a sample of Iraqi cervical cancer patients using Immunohistochemistry Technique. Research Journal of Pharmacy and Technology. 2020; 13(7): 3193-8.
7. Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. The Lancet. 2019 Jan 12; 393(10167): 169-82.
8. Gharpankar P, Mariyappan A, Oak P, Pradnya K, Gupta S, Yewale J. Knowledge and Risk factors of Cervical cancer among women in towns of Pune Division-Maharashtra.
9. Souza AD, Babu D, Gireesh GR. Assess Level of Risk of Cervical Cancer among Women in selected Community Area, Mangalore. Asian Journal of Nursing Education and Research. 2014; 4(4): 461-8.
10. Liu J, Li Z, Lu T, Pan J, Li L, Song Y, Hu D, Zhuo Y, Chen Y, Xu Q. Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China. BMC Medical Genomics. 2022 Dec; 15(1): 1-2.
11. Rajasankar S, Kokilavani N. Diagnostic Efficacy of Pap Smear in Early Detection of Cervical Cancer among Women. International Journal of Advances in Nursing Management. 2017; 5(1): 25-7.
12. Roja U, Koteswaramma D. A Study to Assess the Knowledge regarding Cervical Cancer among women Residing at Rajanagaram. International Journal of Advances in Nursing Management. 2023 Oct; 11(4): 237-44.
13. Moses K, Karthika P, Patel N. Awareness regarding Cervical Cancer among Married Women. Asian Journal of Nursing Education and Research. 2018; 8(4): 515-8.
14. Zammataro L, Lopez S, Bellone S, Pettinella F, Bonazzoli E, Perrone E, Zhao S, Menderes G, Altwerger G, Han C, Zeybek B. Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy. Proceedings of the National Academy of Sciences. 2019 Nov 5; 116(45): 22730-6.
15. Shakila S. A study to assess the Knowledge regarding Cervical Cancer among Women. Asian Journal of Nursing Education and Research. 2015; 5(3): 307-10.
16. Balakrishnan BR. Cervical cancer prevention and treatment: An overview. Research Journal of Pharmacy and Technology. 2021; 14(4): 2353-9. doi: 10.52711/0974-360X.2021.00415
17. Sharma A, Liu H, Herwig-Carl MC, Chand Dakal T, Schmidt-Wolf IG. Epigenetic regulatory enzymes: mutation prevalence and coexistence in cancers. Cancer Investigation. 2021 Mar 16; 39(3): 257-73.
18. Amulya Vijay, V. P. Sona, A. Radha, P. Vinayaga Moorthi. A Review on Advancement Perspectives in Cervical Cancer. Research J. Pharm. and Tech. 2017; 10(12): 4410-4414.
19. Pramanik S, Kutzner A, Heese K. Lead discovery and in silico 3D structure modeling of tumorigenic FAM72A (p17). Tumor Biology. 2015 Jan; 36: 239-49. https://doi.org/10.1007/s13277-014-2620-7
20. Renault L, Chou HT, Chiu PL, Hill RM, Zeng X, Gipson B, Zhang ZY, Cheng A, Unger V, Stahlberg H. Milestones in electron crystallography. Journal of Computer-Aided Molecular Design. 2006 Aug; 20: 519-27.
21. Wang D, Xu M, Li F, Gao Y, Sun H. Target Identification-Based Analysis of Mechanism of Betulinic Acid-Induced Cells Apoptosis of Cervical Cancer SiHa. Natural Product Communications. 2022 Jul; 17(7): 1934578X221115528
22. Sinha VB, Pandey N, Taneja P. Biomarker genes for gynecological cancers. Research Journal of Pharmacy and Technology. 2016; 9(10): 1641-6.
23. Wei Z, Liu X, Cheng C, Yu W, Yi P. Metabolism of amino acids in cancer. Frontiers in Cell and Developmental Biology. 2021 Jan 12; 8: 603837.
24. Chen CL, Hsu SC, Ann DK, Yen Y, Kung HJ. Arginine signaling and cancer metabolism. Cancers. 2021 Jul 15; 13(14): 3541.
25. Goodrich SK, Schlegel CR, Wang G, Belinson JL. Use of artemisinin and its derivatives to treat HPV-infected/transformed cells and cervical cancer: a review. Future Oncology. 2014 Mar; 10(4): 647-54.
26. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics. 2008 Dec; 9: 1-8.
27. Efdi M, Itoh T, Akao Y, Nozawa Y, Koketsu M, Ishihara H. The isolation of secondary metabolites and in vitro potent anti-cancer activity of clerodermic acid from Enicosanthum membranifolium. Bioorganic and Medicinal Chemistry. 2007 Jun 1; 15(11): 3667-71.
28. Li Y, Ma J, Song Z, Zhao Y, Zhang H, Li Y, Xu J, Guo Y. The Antitumor Activity and Mechanism of a Natural Diterpenoid. Combating Cancer with Natural Products: What Would Non-Coding RNAs Bring?. 2021 Nov 5.
29. Xu Z, Huang L, Zhang T, Liu Y, Fang F, Wu X, Chen W, Lan L, Zhang Y, Li N, Hu P. Shikonin inhibits the proliferation of cervical cancer cells via FAK/AKT/GSK3β signalling. Oncology Letters. 2022 Sep 1; 24(3): 1-0.
30. Tang Q, Liu L, Zhang H, Xiao J, Hann SS. Regulations of miR-183-5p and snail-mediated shikonin-reduced epithelial-mesenchymal transition in cervical cancer cells. Drug design, development and therapy. 2020 Feb 11: 577-89.
31. Lüscher-Firzlaff J, Chatain N, Kuo CC, Braunschweig T, Bochyńska A, Ullius A, Denecke B, Costa IG, Koschmieder S, Lüscher B. Hematopoietic stem and progenitor cell proliferation and differentiation requires the trithorax protein Ash2l. Scientific Reports. 2019 Jun 4; 9(1): 8262.
32. Yang Z, Jia Y, Wang S, Zhang Y, Fan W, Wang X, He L, Shen X, Yang X, Zhang Y, Yang H. Retinoblastoma-binding protein 5 regulates H3K4 methylation modification to inhibit the proliferation of melanoma cells by inactivating the Wnt/β-catenin and epithelial-mesenchymal transition pathways. Journal of Oncology. 2023 Feb 21; 2023.